News

Shares of Abacus Life, Inc. (ABL) have gained 2.3% over the past four weeks to close the last trading session at $7.72, but there could still be a solid upside left in the stock if short-term ...
SEONGNAM, South Korea, April 6, 2025 /PRNewswire/ -- ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and ...